20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Sourcing High-Quality ODM-201: Your Trusted Manufacturer in China

In the dynamic field of pharmaceutical research and development, securing high-quality raw materials and advanced intermediates is paramount. For those focused on oncology, particularly prostate cancer therapies, ODM-201 (CAS: 1297538-32-9) represents a significant advancement. As a leading manufacturer and supplier of pharmaceutical intermediates in China, we pride ourselves on providing compounds that meet stringent quality standards, empowering scientific innovation worldwide.

ODM-201 is a cutting-edge androgen receptor (AR) inhibitor that has demonstrated exceptional promise in tackling castration-resistant prostate cancer (CRPC). Its unique ability to act as a potent antagonist against AR mutations that confer resistance to existing treatments, coupled with its favorable safety profile characterized by minimal brain penetrance, makes it a critical component in the development of next-generation cancer therapies. Researchers and formulators are increasingly seeking reliable sources for this compound.

Our company specializes in the synthesis and supply of complex pharmaceutical intermediates. We understand the critical nature of purity, consistency, and timely delivery for our clients. When you choose us as your ODM-201 supplier, you are partnering with a facility that adheres to rigorous quality control measures throughout the entire manufacturing process. This ensures that the ODM-201 you receive is of the highest caliber, suitable for the most demanding research and development applications.

We are dedicated to supporting the global scientific community by making advanced intermediates like ODM-201 accessible. Whether you are conducting preclinical studies, developing new formulations, or scaling up production, our capabilities as a manufacturer in China allow us to offer competitive pricing and a stable supply chain. For procurement managers and research scientists looking to buy ODM-201, we invite you to inquire about our product specifications, pricing, and sample availability. Partner with us for your critical intermediate needs.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Understanding ODM-201: A Next-Gen AR Inhibitor for Prostate Cancer

Next: The Role of ODM-201 in Overcoming AR Resistance in Prostate Cancer

All Rights Reserved